Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D001120:Arginine; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D002940:Circadian Rhythm; D003093:Colitis, Ulcerative / Q000188:drug therapy; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007328:Insulin / Q000097:blood*; D008797:Metyrapone; D009404:Nephrotic Syndrome / Q000188:drug therapy; D010912:Pituitary-Adrenal Function Tests; D011241:Prednisone / Q000008:administration & dosage; D011863:Radioimmunoassay
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D001786:Blood Glucose; D007328:Insulin; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D001120:Arginine; D011241:Prednisone; D006854:Hydrocortisone; D008797:Metyrapone